|
AU2002250419A1
|
|
Novel nucleic acids and polypeptides
|
|
WO02077257A1
|
|
Novel nucleic acids and polypeptides
|
|
WO02074961A1
|
|
Novel nucleic acids and polypeptides
|
|
CA2441006A1
|
|
Methods and materials relating to fibulin-like polypeptides and polynucleotides
|
|
WO02066600A2
|
|
Methods and materials relating to leukocyte immunoglobulin receptor-like (lir-like) polypeptides and polynucleotides
|
|
AU3516502A
|
|
Novel nucleic acids and polypeptides
|
|
AU2002246502A1
|
|
Nucleic acids and polypeptides
|
|
AU1325902A
|
|
Egf motif protein, egfl6 materials and methods
|
|
CA2425827A1
|
|
Novel nucleic acids and polypeptides
|
|
US2002012941A1
|
|
Method for screening for unknown organisms
|
|
WO0222780A2
|
|
Methods and materials relating to neuropilin-like polypeptides and polynucleotides
|
|
CA2421949A1
|
|
Novel nucleic acids and polypeptides
|
|
AU9256101A
|
|
Novel nucleic acids and polypeptides
|
|
AU7345601A
|
|
Soluble immunoglobulin e receptor alpha like molecules
|
|
AU6492001A
|
|
Therapeutic uses of il-1 receptor antagonist
|
|
AU6472401A
|
|
Novel bone marrow nucleic acids and polypeptides
|
|
CA2409164A1
|
|
Novel nucleic acids and polypeptides
|
|
AU6300601A
|
|
Novel nucleic acids and polypeptides
|
|
WO0179447A2
|
|
Novel bone marrow nucleic acids and polypeptides
|
|
CA2406039A1
|
|
Materials and methods relating to lipid metabolism
|
